GMS | Deutscher Rheumatologiekongress 2023 | Development of a Mi-2a antibody in therapy-refractory Jo-1 positive anti-synthethase syndrome: A retrospective analysis with two patients

Figure 1: Seroconversion into Mi2a-positivity in two patients of Jo-1+ antisynthetase syndrome during their course of disease

gms | German Medical Science